Modulation of Vα19 NKT cell immune responses by α-mannosyl ceramide derivatives consisting of a series of modified sphingosines

European Journal of Immunology

Volumn 37, Issue 7, 2007, Pages 1836-1844

  Shimamura, Michio ^a   Huang, Yi Ying ^a   Okamoto, Naoki ^a   Suzuki, Nahoko ^a   Yasuoka, Jouji ^b   Morita, Kenji ^b   Nishiyama, Akira ^b   Amano, Yuusuke ^b   Mishina, Tadashi ^b  

^a MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Glycolipids; Invariant TCR; KNT cell; Rodents; Th1 Th2

Indexed keywords

ALPHA MANNOSYLCERAMIDE DERIVATIVE; CERAMIDE DERIVATIVE; GLYCOLIPID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SPHINGOSINE; UNCLASSIFIED DRUG; CERAMIDE; CYTOKINE; GLYCOSPHINGOLIPID; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR; MR1 PROTEIN, HUMAN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; C57BL 6 MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOTHERAPY; IN VIVO STUDY; LEUKOCYTE CULTURE; LEUKOCYTE FUNCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; COCULTURE; GENETIC TRANSFECTION; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; CELLS, CULTURED; CERAMIDES; COCULTURE TECHNIQUES; CYTOKINES; GLYCOSPHINGOLIPIDS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPHINGOSINE; T-LYMPHOCYTE SUBSETS; TRANSFECTION;

EID: 34447554385     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636689     Document Type: Article

References (31)

1. Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535-562.
2. - T cells in mice and humans. J. Exp. Med. 1994. 180: 1097-1106.
3. + T cell populations. Int. Immunol. 1995. 7: 1157-1161.
4. + thymocytes selected by MHC class I molecules. Science 1994. 263: 1774-1778.
5. + T lymphocytes. Science 1995. 268: 863-865.
6. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H. et al., CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
7. Natori, T., Koezuka, Y. and Higa, T., Agelasphins, novel α-galactosylceres from the marine sponge Agelas Mauritianus. Tetrahedron Lett. 1993. 34: 5591-5592.
8. Kinjo, Y., Wu, D., Kim, G., Xing, G.-W., Poles, M. A., Ho, D. D., Tsuji, M. et al., Recognition of bacterial glycosphingolipids by natural killer T cell. Nature 2005. 434: 520-525.
9. Mattner, J., DeBord, K. L., Ismail, N., Goff, R. D., Cantu III, C., Zhou, D., Saint-Mezard, P. et al., Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005. 434: 525-529.
10. Zhou, D., Mattner, J., Cantu III, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y. et al., Lysosomal glycosphingolipid recognition by NKT cells. Science 2004. 306: 1786-1789.
11. Shimamura, M. and Huang, Y.-Y., Presence of a novel subset of NKT cells bearing an invariant Vα.19.1-Jα26 TCR α chain. FEBS Lett. 2002. 516: 97-100.
12. Tilloy, F., Treiner, E., Park, S.-H., Garcia, G., Lemonnier, F., de la Salle, H., Bendelac, A. et al., An invariant T cell receptor α chain defines a novel TAP-independent major hitocompatibility complex class Ib-restricted α/β T cell subpopulation in mammals. J. Exp. Med. 1999. 189: 1907-1921.
13. Treiner, E., Duban, L., Bahram, S., Radosavijevic, M., Wanner, V., Tilloy, F., Affaticati, P. et al., Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 2003. 422: 164-169.
14. H2 response and in immunoglobulin E production. Science 1995. 270: 1845-1847.
15. Okamoto, N., Kanie, O., Huang, Y.-Y., Fujii, R., Watanabe, H. and Shimamura, M., Synthetic α-mannosyl ceramide as a potent stimulant for a novel NKT cell repertoire bearing the invariant Vα19-Jα26 TCR α chain. Chemistry & Biology 2005. 12: 677-683.
16. Huang, S., Giffillan, S., Cella, M., Miley, M. J., Lantz, O., Lybarger, L., Fremont, D. H. and Hansen, T. H., Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J. Biol. Chem. 2005. 280: 21183-21193.
17. Fujita, T., Hirose, T., Hamamichi, N., Kitao, Y., Sasaki, S., Yoneta, M. and Chiba, K., 2-Substituted 2-aminoethanol: minimum essential structure for immunosuppressive activity of ISP-I (myocin). Bioorg. Med. Chem. Lett. 1995. 5: 1857-1860.
18. Shimamura, M., Okamoto, N., Huang, Y.-Y., Yasuoka, J., Morita, K., Nishiyama, A., Amano, Y. and Mishina, T., Induction of promotive rather than suppressive immune responses from a novel NKT cell repertoire Vα19 NKT cell with α-mannosyl ceramide analogues consisting of the immuno-suppressant ISP-I as the sphingosine unit. Eur. J. Med. Chem. 2006. 41: 569-576.
19. Pulvertaft, J. V., Cytology of Burkitt's tumor (African lymphoma). Lancet 1964. 1: 238-240.
20. Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Millingan, J., Thornton, R., Shei, G.-J. et al., Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002. 296: 346-349.
21. Oki, S., Chiba, A., Yamamura, T. and Miyake, S., The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NK T cells. J. Clin. Invest. 2004. 113:1631-1640.
22. Hilliard, B. A., Mason, N, Xu, N., Sun, J., Lamhamedi-Cherradi, S.-E., Liou, C. Hunter, H.-C. and Chen, Y. H., Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J. Clin. Invest. 2002. 110: 843-850.
23. Illés, Z., Shimamura, M., Newcombe, J., Oka, N. and Yamamura, T., Accumulation of Vα7.2-Jα33 invariant T cells in human autoimmune inflammatory lesions. Int. Immunol. 2004. 16: 223-230.
24. Croxford, J. L., Miyake, S., Huang, Y.-Y., Shimamura, M. and Yamamura, T., Invariant Vα19i T cells regulate autoimmune inflammation. Nat. Immunol. 2006. 7: 987-994.
25. Mombaerts, P. A., Clarke, R., Rundnicki, M. A., Iacomini, S., Lafaille, J. J., Wang, L., Ichikawa, Y. et al., Mutations in T cell receptor genes α and β block thymocytes development at different stages. Nature 1992. 360: 225-231.
26. + T cells in vitro from fetal liver precursors. J. Immunol. 1997. 158: 3682-3689.
27. Hashimoto, K., Hirai, M. and Kurokawa, Y., A gene outside the human MHC related to classical HLA I genes. Science 1995. 269: 693-695.
28. Niwa, H., Yamamura, K. and Miyazaki, J., Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991. 108: 193-199.
29. POS T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 1994. 179: 1285-1295.
30. Schatz, P. J., Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology 1993. 11: 1138-1143.
31. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I. and Davis, M. M., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.